Which glaucoma implant wins? study pits baerveldt against ahmed
NCT ID NCT04542616
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared two types of tube shunts (Baerveldt 350 and Ahmed ClearPath 250) in 80 adults with glaucoma that was not controlled by other treatments. The goal was to see which device lowers eye pressure better and is safer. Both implants are used to drain fluid and protect vision.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Ira G. Ross Eye Institute
Buffalo, New York, 14209, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a bangkok community eye check reveal hidden glaucoma risks?
- AI eye exam: a new hope for early glaucoma detection?
- Can a tiny eye implant replace glaucoma drops?
- Can a new tube implant surgery outperform standard glaucoma surgery?
- Could your personality predict glaucoma drug side effects?
- Could a single eye implant replace years of glaucoma drops?